Skip to main content

Sunitinib elicits “exceptional” response in refractory thymic carcinoma

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Sunitinib elicits “exceptional” response in refractory thymic carcinoma

User login

Username

Password

Reset your password

Type	Lead	score